Cargando…

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kommoss, Felix KF, Karnezis, Anthony N., Kommoss, Friedrich, Talhouk, Aline, Taran, Florin-Andrei, Staebler, Annette, Gilks, C. Blake, Huntsman, David G., Krämer, Bernhard, Brucker, Sara Y., McAlpine, Jessica N., Kommoss, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134076/ https://www.ncbi.nlm.nih.gov/pubmed/30050154 http://dx.doi.org/10.1038/s41416-018-0187-6

Ejemplares similares

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
por: Kommoss, Stefan, et al.
Publicado: (2016)

Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series
por: Grube, Marcel, et al.
Publicado: (2022)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review
por: Kommoss, S, et al.
Publicado: (2017)

A clinically applicable molecular-based classification for endometrial cancers
por: Talhouk, A, et al.
Publicado: (2015)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
por: Marnitz, Simone, et al.
Publicado: (2020)

Three-dimensional virtual histology of benign and malignant endometrial stromal neoplasms: a new perspective on why morphology matters
por: Kommoss, Felix KF, et al.
Publicado: (2021)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
por: Mackenzie, Robertson, et al.
Publicado: (2015)

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
por: Karnezis, Anthony N, et al.
Publicado: (2015)

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care
por: Talhouk, A., et al.
Publicado: (2016)

Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease
por: Pilsworth, Jessica A, et al.
Publicado: (2021)

Adhesion prevention after endometriosis surgery — results of a randomized, controlled clinical trial with second-look laparoscopy
por: Krämer, Bernhard, et al.
Publicado: (2021)

Improvement in Fertility and Pain after Endometriosis Resection and Adhesion Prevention with 4DryField(®) PH: Follow-up of a Randomized Controlled Clinical Trial
por: Krämer, Bernhard, et al.
Publicado: (2023)

Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
por: Kommoss, S, et al.
Publicado: (2007)

Atypical course of a caesarean scar pregnancy
por: Schlammerl, Katharina, et al.
Publicado: (2022)

Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
por: Imle, Roland, et al.
Publicado: (2021)

Large Conization—Retrospective Monocentric Results for Fertility Preservation in Young Women with Early Stage Cervical Cancer
por: Tsaousidis, Christos, et al.
Publicado: (2021)

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
por: Heinze, Karolin, et al.
Publicado: (2023)

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
por: Sengal, Asmerom T, et al.
Publicado: (2022)

Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
por: Bae, Gyuntae, et al.
Publicado: (2023)

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
por: Hanley, Gillian E., et al.
Publicado: (2018)

Genomic characterization of DICER1-associated neoplasms uncovers molecular classes
por: Kommoss, Felix K. F., et al.
Publicado: (2023)

Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention
por: Hanley, Gillian E., et al.
Publicado: (2022)

Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction
por: Talhouk, Aline, et al.
Publicado: (2016)

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations
por: Otte, Anna, et al.
Publicado: (2015)

Safety and effectiveness of a novel generator algorithm for bipolar vessel sealing: a randomised controlled chronic animal study
por: Kraemer, Bernhard, et al.
Publicado: (2019)

Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
por: Arora, Nimisha, et al.
Publicado: (2018)

Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
por: Weissinger, Matthias, et al.
Publicado: (2022)

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
por: Vogel, Rachel Isaksson, et al.
Publicado: (2016)

From biobank and data silos into a data commons: convergence to support translational medicine
por: Asiimwe, Rebecca, et al.
Publicado: (2021)

Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup
por: Kommoss, Felix K. F., et al.
Publicado: (2021)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors
por: Plett, Helmut, et al.
Publicado: (2020)

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
por: Jamieson, Amy, et al.
Publicado: (2021)

Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line
por: Wang, Yemin, et al.
Publicado: (2020)

Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways
por: Marshall, A., et al.
Publicado: (2023)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4tpq96asccbmbgm95kg9fccne8